• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition

$6,000.00 – $12,000.00

Clear
SKU: 23-031 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Tags: coronavirus, COVID-19, pandemic, POC Colon Cancer Screening Market, POC COVID-19 Market, POC Glucose Testing Market, POC Infectious Disease Testing Market, POC Professional Testing Market, POC Self-Testing Market, POC Testing Market, Point-of-Care (POC) Diagnostics, Point-of-care (POC) Testing Pages: 600
  • Description
  • Table of Contents
  • Latest reports

Description

The point-of-care diagnostics market has long been the opportunity market within IVD.  Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters.  While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area.  There are more companies in the point of care market, and it is a top segment of investment.

Now in Ten Editions

Kalorama’s report is used by top POC IVD companies because it provides objective, well-supported estimates of the size and growth of this important IVD market segment.

How can diagnostics promote wellness? How can diagnostics improve patient-provider encounters?  How can tests promote better selection and stewardship of drugs?  How can tests facilitate patient home or nursing home of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled?  The answers to these questions in many ways rely on the success of point-of-care.  This means you need a resource, updated yearly, to keep up with the changes in the marketplace.

Enhanced Segmentation – Many Reports in One

Kalorama’s report is designed to provide information on all major segments of point of care, so that you do not need to spend dollars on a report. While point of care has always been an area companies seek growth, recently market growth has changed in many categories.  Kalorama documents these areas in its report:

  • Glucose
  • Coagulation
  • CRP
  • Other Cardiac Markers
  • Coagulation
  • Colon Cancer
  • Pregnancy / Fertility
  • Drugs of Abuse
  • hbA1c
  • Cholesterol
  • HIV
  • COVID-19
  • Other Infectious Disease
  • Critical Care Tests

These are detailed with market sizing and forecast in this report.

As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home.

Where Tests are Conducted – Venue Market Analysis

POC tests are performed in a wide range of geographical locations such as:

  • Hospital departments such as emergency departments, operating rooms, intensive care units, and others
  • Physicians’ offices
  • Hospital clinics
  • Retail clinics
  • Pharmacies
  • Homes – With testing performed by patients, visiting nurses, or other caregivers
  • Nursing homes

POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

International Coverage

POC is an international market and Kalorama reflects this with regional coverage.

Analysis is anchored by:

  • Europe
  • Japan
  • United States
  • Rest of World

Other countries and regions discussed in the report include:

  • Australia
  • Canada
  • China
  • France
  • Germany
  • India
  • Italy
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Latin America
  • Middle East

Keep Up With the Most Competitive IVD Sector  

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use.  At the same time, more decentralized test venues invest in non-waived rapid tests and instruments.  POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care.  New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.

This report breaks out point of care testing by segment.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

  • 1 Step Detect Associates, Llc
  • Abbott Laboratories
  • Abingdon Health Ltd.
  • Accessbio, Inc.
  • Accubiotech Co, Ltd.
  • Acon Laboratories, Inc
  • Aerscher Diagnostics, Llc
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • Arkray, Inc.
  • Artron Laboratories, Inc
  • Ascensia Diabetes Care Holdings Ag
  • Atlas Link Biotech Co., Ltd
  • Autobio Diagnostics Co., Ltd
  • Beckman Coulter, Inc
  • Becton Dickinson (Bd)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (Bbi)
  • Binx Health
  • Biolytical Laboratories
  • Biomedomics, Inc
  • Biomeme, Inc
  • Biomerica, Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Biosensia Ltd.
  • Biotron Diagnostics, Inc.
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • Btnx Inc.
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostics, Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, Llc
  • Confirm Biosciences
  • Ctk Biotech, Inc.
  • Cue Health
  • Danaher Corporation
  • Dexcom, Inc
  • Dialab Gmbh
  • Diasys Diagnostic Systems Gmbh
  • Diazyme Laboratories, Inc.
  • Dna Electronics Ltd. (Dnae)
  • Fooke-Achterrath Laboratorien Gmbh
  • Dxgen Corp.
  • Eiken Chemical Co Ltd.
  • Ekf Diagnostics Holdings Plc
  • Elitechgroup S.A.S.
  • Enterix, Inc. (Clinical Genomics)
  • Eurobio Scientific
  • Everlywell
  • Exact Sciences
  • Ey Laboratories
  • First Check Diagnostics Llc
  • Genbio
  • Genedrive Plc
  • Getein Biotech Inc.
  • Glysby Diagnostics
  • Helena Laboratories
  • Hemosure, Inc.
  • Horiba, Ltd.
  • Immune Iq
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • Jal Innovation Pte Ltd
  • Jant Pharmacal Corporation
  • Mitra & Co Pvt. Ltd
  • Lamdagen Corporation
  • Lifescan, Inc
  • Lifesign, Llc
  • Lightdeck Diagnostics
  • Lumiradx Uk Limited
  • Macherey-Nagel Gmbh & Co. Kg
  • Medix Biochemica
  • Medmira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics Srl.
  • Meridian Bioscience, Inc
  • Mico Biomed Usa
  • Nano-Ditech Corporation
  • Ng Biotech
  • Noble Medical, Inc
  • Nova Biomedical Corp.
  • Oasis Diagnostics Corporation
  • Operon S.A.
  • Opko Health, Inc
  • Orasure Technologies, Inc.
  • Polymedco, Inc
  • Polymer Technologies, Inc (Pts Diagnostics)
  • Preventis Gmbh
  • Princeton Biomeditech Corporation
  • Quantumdx Group Limited
  • Quidelortho Corporation
  • Radiometer Medical A/S
  • Randox Laboratories Limited
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Savyon Diagnostics
  • Sekisui Diagnostics Llc
  • Siemens Healthineers Gmbh
  • Sysmex Corporation
  • Techlab, Inc.
  • Trinity Biotech Plc
  • Trividia Health
  • Tulip Diagnostics Ltd (Tulip Group)
  • Vedalab
  • Veredus Laboratories Pte Ltd
  • Werfen

Scope and Methodology

The  geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers.  Additionally, key company profiles are included.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2022, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2022-2026 periods for each segment covered.  Competitive analysis is provided for the year 2022 along with regional breakdowns.  The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary

Introduction

Scope and Methodology

Size and Growth of the Market

  • Table 1-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)

Trends Affecting the Market

Competitive Outlook

Market Conclusions

Conclusion One – POC market transformed by technological progress

Conclusion Two – POC Molecular Diagnostics continue making inroads

Conclusion Three – Prevention and early detection at nexus of POC development

Conclusion Four – Wearables continue to influence POC market

Conclusion Five – Test cost will continue to be an issue worldwide

Conclusion Six – Rising demand will drive POC market in RoW markets

Conclusion Seven – New venues – urgent & retail care

Conclusion Eight – COVID-19’s positive effect

Conclusion Nine – Insurance coverage for OTC COVID-19 testing

Conclusion Ten – New Opportunities in POC Infectious Disease Testing

Conclusion Eleven – Supply Chain Delays

Conclusion Twelve – Multiplex Testing Explodes

Conclusion Thirteen – AI Making Inroads into POC

Chapter 2: Introduction and Overview

Point-of-Care Diagnostics Testing

Industry Regulations

Types of CLIA Certificates

POC Industry Drivers

Patient focused drivers

Medical/Healthcare related drivers

Technology drivers

Economic drivers

Other drivers

POC Industry Challenges

POC Test Types

Blood

Urine

Saliva

Hair

Optical Technologies

Breath

Conditions Evaluated by POC Diagnostic Testing

Cancer

Colorectal Cancer

Prostate Cancer

Cardiovascular Disease

Diabetes

Drug Abuse

Infectious Disease

Herpes

HTLV

Respiratory Syncytial Virus

Hepatitis

Lyme Disease

Babesiosis

Gonorrhea, Syphilis and Chlamydia

Trichomonas Vaginalis

HIV/AIDS

Helicobacter Pylori

Influenza

Coronavirus

Mononucleosis

Streptococcus

Osteoporosis

Pregnancy and Fertility

Chapter 3: POC Blood Glucose Tests

Types of Blood Glucose Testing

Fasting Blood Sugar (FBS)

2-Hour Postprandial Blood Sugar (PPBS)

Random Blood Sugar

Glucose Tolerance Test

Glucose Urine Test

Glycated Hemoglobin (HbA1c)

Products

Blood Glucose Self-Testing

  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT

Continuous Self-Testing

Glycated Hemoglobin Tests

  • Table 3-3: Selected POC HbA1c Devices

Professional

Market Size and Growth

  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 3-5:  Global POC Diabetes Sales by Test Category, 2022-2027 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)

Regional Analysis

  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2022 (%)

POC Glucose Self-Testing

  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2022-2027 (in millions $ at manufacturer level)

POC Continuous Glucose Self-Testing

  • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2022-2027 (in millions $ at manufacturer level)

POC Glucose Professional Testing

  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2022-2027 (in millions $ at manufacturer level)

POC HbA1c Testing

  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2022-2027 (in millions $ at manufacturer level)

COVID-19 Impact

Competitive Analysis

  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), 2022 (in millions $)
  • Figure 3-2: Global POC Glucose Test Manufacturers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), by Percent, 2022 (%)

Chapter 4: POC Blood and Electrolytes Testing Market

Types of Blood and Electrolytes Tests

Hemoglobin/Hematocrit

WBC and Other

Blood Gases

Electrolytes

Products

  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2022
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2022

Market Size and Growth

  • Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis), 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category (Blood Gases & Electrolytes, Hematocrit/Hemoglobin, WBC other routine) 2022-2027 ($ millions)

Regional Analysis

  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2022 (%)

POC Blood and Electrolyte Self-Testing

  • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Blood and Electrolyte Professional Testing

  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), 2022 (in millions $)
  • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), by Percent, 2022

Chapter 5: POC Rapid Coagulation

Products

  • Table 5-1: Selected POC Coagulation Test Innovations

Platelet Testing

  • Table 5-2: Selected Platelet Activity Test Innovations

Market Size and Growth

  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2022 (%)

POC Rapid Coagulation Self-Testing

  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Rapid Coagulation Professional Testing

  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Radiometer, Roche Diagnostics, Siemens Healthineers, Werfen, Others), 2022 (in millions$)
  • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers (Abbott, Radiometer, Instrumentation Labs, Roche Diagnostics, Siemens Healthineers, Others), 2022

Chapter 6: POC Rapid Cardiac Markers

Products

Market Size and Growth

  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

COVID-19 Impact

Competitive Analysis

  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers (Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
  • Figure 6-2: Global POC Cardiac Markers Test Manufacturers (Abbott, QuidelOrtho, Roche, Siemens, Others), by Percent, 2022

Chapter 7: POC Substance Abuse

Overview

Products

Urine

Oral

Blood

Hair

Market Size and Growth

  • Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

POC Drugs of Abuse Self-Testing

  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2022-2027 ($ millions at the manufacturer’s level)

POC Drugs of Abuse Professional Testing

  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), 2022 (in millions of $)
  • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), by Percent, 2022

Chapter 8: POC Pregnancy and Fertility Testing

Products

  • Table 8-1:  Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay

Market Size and Growth

  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

POC Pregnancy and Fertility Self-Testing

  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Pregnancy and Fertility Professional Testing

  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers (bioMérieux, Church & Dwight, Meridian, Quidel, SPD, Others), 2022 (in millions $)
  • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers (bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others), by Percent, 2022

Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing

Products

  • Table 9-1: Selected POC Colon Cancer Tests

Market Size and Growth

  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

POC Colon Cancer Screening/Fecal Occult Blood Self-Testing

  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing

  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, Exact Sciences, Others), 2022 (in millions $)
  • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers (Beckman Coulter, Exact Sciences, Others), by Percent, 2022

Chapter 10: POC Infectious Disease Testing

Products

HIV and Hepatitis

Respiratory

STD/STI

Tropical Diseases

Lyme Disease

Tuberculosis (TB)

Zika

Anthrax

Other Viruses

Hospital Acquired Infections and Sepsis

Sepsis

C.Diff

  • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics

COVID-19

Antigen

Serology

Molecular

Market Size and Growth

  • Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

POC Infectious Disease Self-Testing

  • Table 10-3: POC Infectious Disease Self-Testing(including COVID-19) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Infectious Disease Professional Testing

  • Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer’s level)

POC Infectious Disease Testing by Disease Type

  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type (C. difficile, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza. Malaria, Other Respiratory, STD, Others), 2022 (in millions $)
  • Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home Test/OTC, Others) Percent by Disease Type 2022
  • Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff), Percent by End-user (Hospital including reference labs, physician office labs (POL) and Nursing Homes, pharmacy, home use and others), 2022

Competitive Analysis

  • Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
  • Figure 10-4: Global POC Infectious Disease Test Manufacturers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), by Percent, 2022

Chapter 11: POC Lipid Testing

Products

Market Size and Growth

  • Table 11-1: Global POC Lipid Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

POC Lipid Self-Testing

  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Lipid Professional Testing

  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers  2022 (in millions $)
  • Figure 11-2: Global POC Lipid Testing Manufacturers (Abaxis/Zoetis, Abbott, Roche, Others), by Percent, 2022 (%)

Chapter 12: POC Cancer Tumor Marker Testing

Products

  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications

Market Size and Growth

  • Table 12-2: Global POC Cancer Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

COVID-19 Impact

Competitive Analysis

  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), 2022 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), by Percent, 2022

Chapter 13: POC Urine Testing

Products

Market Size and Growth

  • Table 13-1: Global POC Urine Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Regional Analysis

  • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

POC Urine Self-Testing

  • Table 13-2: POC Urine Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

POC Urine Test Professional Testing

  • Table 13-3: POC Urine Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

COVID-19 Impact

Competitive Analysis

  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), 2022 (in millions $)
  • Figure 13-2: Global POC Urine Strip Testing Manufacturers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), by Percent, 2022

Chapter 14: Miscellaneous POC Testing

Microbiology

TSH

Allergy

Autoimmune

Others

Market Size and Growth

  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 14-2:  Global POC Miscellaneous Sales, by Test Category (Microbiology, TSH, Allergy, Autoimmune, Others), 2022-2027 ($ millions)

Regional Analysis

  • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

Chapter 15: Issues and Trends

Overview

Wearables

  • Table 15-1: Selected Wearable Devices

Mobile Healthcare Technologies

Telehealth

Telehealth eMed to Implement Home Test to Treat Program

Patient-centered Healthcare

Breath Test Advances

  • Table 15-2: Selected Disease Markers in Exhaled Breath

Regulatory Hurdles

Reimbursement Challenges

PAMA

Competition

POC and Molecular Diagnostics

  • Table 15-3:  Selected Market Available Molecular POC Diagnostic Platforms

POC Biosensors and Microfluidics

  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2022
  • Table 15-5: Selected Biochip and Biosensor Players, 2022

China as a POC Market

Emerging POC Technologies

POC Connectivity

COVID-19 Impact

Multiplexed POC Testing

  • Figure 15-1: Multiplexed POC Testing Schematic

The Emergence of Non-invasive Technologies

Saliva and Swab

Optical Techniques

Near-infrared Scanning

Volatolomics

POC and Antibiotic Resistance Concern

Artificial Intelligence in POC

POC Future in Infectious Disease Diagnostics

Supply Chain Delays

Insurance Coverage for OTC Diagnostic Tests

Chapter 16: Total Global POC Testing Market and Competitor Analysis

Market Overview

  • Table 16-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)

Market Analysis by Product Categories

  • Table 16-2: Global POC Testing Market Analysis by Product Category (Self-Testing, Professional Testing), 2022 (in millions $)

Market Analysis by Subcategory

POC Self-Testing

  • Table 16-3: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (in millions$)
  • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (%)

POC Professional Testing

  • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous), 2022 (in millions$)
  • Figure 16-2 : Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose/HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Other), 2022  (by %)

POC Testing by End-Use

  • Figure 16-3: POC Testing by End-User (Hospitals and Reference Labs, Nursing Homes/Pharmacies/Home, Physician Office Labs), 2022

Market by Device Technology

  • Figure 16-4: Global POC Market by Technology (Analyzers, Biosensor, LFA, Strips), by Sales 2022 by %

Market Analysis by Country

United States

  • Table 16-5: US POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Europe

  • Table 16-6: Europe POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
  • Table 16-7: Global POC Testing Market Analysis by European Region, 2022 (in millions $)

Germany

France

UK

Switzerland and Sweden

Other

  • Figure 16-5: Europe POC Testing Percentage Participation, by Country (France, Germany, Italy, Spain, Switzerland, Sweden, United Kingdom, Others), 2022 (%)

Japan

  • Table 16-8: Japan POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)

Rest of World

Latin America

China

India

South Korea

Other RoW Countries

  • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America/Middle East/Canada, South Korea/Other Asian Countries, Other), 2022 (in millions $)
  • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America, South Korea, Other), 2022 (%)
  • Table 16-10: Global POC Testing Analysis by Region/Country (Europe, Japan, United States, Rest of World), 2022 (in millions $)
  • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country (Europe, Japan, United States, Rest of World), 2022 (%)

COVID-19 Impact

Competitive Analysis

  • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (in millions $)
  • Figure 16-8: Global POC Testing Market Share by Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, bioMérieux, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (%)

Chapter 17: Corporate Profiles

Overview

1 Step Detect Associates, LLC

  • Table 17-1: 1-Step Detect Associates Corporate Summary

Company Overview

Products

Abbott Laboratories

  • Table 17-2: Abbott Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-3: Abbott Revenues 2020-2022 (in millions $)

Abingdon Health Ltd.

  • Table 17-4: Abingdon Health Corporate Summary

Company Overview

Products

COVID-19

AccessBio, Inc.

  • Table 17-5: AccessBio Corporate Summary

Company Overview

Products

COVID-19

AccuBioTech Co, Ltd.

Table 17-6: AccuBioTech Corporate Summary

Company Overview

Products

COVID-19

ACON Laboratories, Inc

  • Table 17-7: ACON Laboratories Corporate Summary

Company Overview

Products

COVID-19

Aerscher Diagnostics, LLC

  • Table 17-8: Aerscher Diagnostics Corporate Summary

Company Overview

Products

Alfa Scientific Designs, Inc

  • Table 17-9: Alfa Scientific Corporate Summary

Company Overview

Products

COVID-19

American Bio Medica Corporation

  • Table 17-10: American Bio Medica Corporate Summary

Company Overview

Products

COVID-19

ARKRAY, Inc.

  • Table 17-11: ARKRAY Corporate Summary

Company Overview

Products

Artron Laboratories, Inc

  • Table 17-12: Artron Laboratories Corporate Summary

Company Overview

Products

COVID-19

Ascensia Diabetes Care Holdings AG

  • Table 17-13: Ascensia Diabetes Care Corporate Summary

Company Overview

Products

Atlas Link Biotech Co., Ltd

  • Table 17-14: Atlas Link Biotech Corporate Summary

Company Overview

Products

COVID-19

Autobio Diagnostics Co., Ltd

  • Table 17-15: Autobio Diagnostics Corporate Summary

Company Overview

Products

COVID-19

Beckman Coulter, Inc

  • Table 17-16: Beckman Coulter Corporate Summary

Company Overview

Products

COVID-19

Company Financials

  • Table 17-17: Beckman Coulter Revenue (2020-2022) ($ millions)

Becton Dickinson (BD)

  • Table 17-18: BD Corporate Summary

Company Overview

Products

COVID-19

Company Financials

  • Table 17-19: BD Corporation Revenue (2020-2022) ($ millions)

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

  • Table 17-20:  Beijing Wantai Biological Pharmacy Enterprise Corporate Summary

Company Overview

Products

COVID-19

Bhat Bio-Tech India Private Ltd. (BBI)

  • Table 17-21: Bhat Bio-Tech India Private Corporate Summary

Company Overview

Products

COVID-19

binx health

  • Table 17-22: binx health Corporate Summary

Company Overview

Products

COVID-19

bioLytical Laboratories

  • Table 17-23: bioLytical Laboratories Corporate Summary

Company Overview

Products

COVID-19

BioMedomics, Inc

  • Table 17-24: BioMedomics Corporate Summary

Company Overview

Products

COVID-19

Biomeme, Inc

  • Table 17-25: Biomeme Corporate Summary

Company Overview

Products

Biomerica, Inc.

  • Table 17-26: Biomerica Corporate Summary

Company Overview

Products

COVID-19

Company Financials

  • Table 17-27: Biomerica Corporation Revenue (2020-2022) ($ millions)

bioMérieux SA

  • Table 17-28: bioMerieux SA Corporate Summary

Company Overview

Products

COVID-19

Company Financials

  • Table 17-29: bioMerieux Revenues (2020-2022) ($ millions)

Bio-Rad Laboratories Inc.

  • Table 17-30: Bio-Rad Labs Corporate Summary

Company Overview

Products

Company Financials

  • Table 17-31: Bio-Rad Corporation Revenue (2020-2022) ($ millions)

Biosensia Ltd.

  • Table 17-32: Biosensia Corporate Summary

Company Overview

Products

Biotron Diagnostics, Inc.

  • Table 17-33: Biotron Diagnostics Corporate Summary

Company Overview

Products

Boditech Med Inc

  • Table 17-34: Boditech Med Corporate Summary

Company Overview

Products

COVID-19

Boson Biotech Co. Ltd

  • Table 17-35: Boson Biotech Corporate Summary

Company Overview

Products

COVID-19

BTNX Inc.

  • Table 17-36: BTNX Corporate Summary

Company Overview

Products

COVID-19

Calypte Biomedical Corporation

  • Table 17-37: Calypte Biomedical Corporate Summary

Company Overview

Products

Cepheid, Inc

  • Table 17-38: Cephid Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-39: Cepheid Revenues (2020-2022) ($ millions)

Chembio Diagnostics, Inc.

  • Table 17-40: Chembio Diagnostic Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-41: Chembio Diagnostics Revenues (2020-2022) ($ millions)

Church & Dwight Co. Inc

  • Table 17-42: Church & Dwight Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-43: Church and Dwight Revenues (2020-2022) ($ millions)

Clarity Diagnostics, LLC

  • Table 17-44: Clarity Diagnostics Corporate Summary

Company Overview

Products

COVID-19

Confirm Biosciences

  • Table 17-45: Confirm Biosciences Corporate Summary

Company Overview

Products

COVID-19

CTK Biotech, Inc.

  • Table 17-46: CTK Biotech Corporate Summary

Company Overview

Products

COVID-19

Cue Health

  • Table 17-47:  Cue Health Corporate Summary

Company Overview

Products

COVID-19

Danaher Corporation

  • Table 17-48: Danaher Corporation Summary

Company Overview

Products

Dexcom, Inc

  • Table 17-49: Dexcom Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-50:  Dexcom Revenues (2020-2022) ($ millions)

DIALAB GmbH

  • Table 17-51: DIALAB Corporate Summary

Company Overview

Products

COVID-19

DiaSys Diagnostic Systems GmbH

  • Table 17-52: DiaSys Diagnostic Systems Corporate Summary

Company Overview

Products

COVID-19

Diazyme Laboratories, Inc.

  • Table 17-53: Diazyme Laboratories Corporate Summary

Company Overview

Products

COVID-19

DNA Electronics Ltd. (DNAe)

  • Table 17-54: DNA Electronics Corporate Summary

Company Overview

Products

Dr. Fooke-Achterrath Laboratorien GmbH

  • Table 17-55:  Dr. Fooke-Achterrath Laboratorien Corporate Summary

Company Overview

Products

COVID-19

DxGen Corp.

  • Table 17-56:  DxGen Corporate Summary

Company Overview

Products

COVID-19

Eiken Chemical Co Ltd.

  • Table 17-57: Eiken Chemical Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-58:  Eiken Chemical Revenues (2020-2022 ($ millions)

EKF Diagnostics Holdings plc

  • Table 17-59: EKF Diagnostics Corporate Summary

Company Overview

Products

ELITechGroup S.A.S.

  • Table 17-60: ELITechGroup Corporate Summary

Company Overview

Products

COVID-19

Enterix, Inc. (Clinical Genomics)

  • Table 17-61: Enterix Corporate Summary

Company Overview

Products

Eurobio Scientific

  • Table 17-62:  Eurobio Scientific Corporate Summary

Company Overview

Products

COVID-19

Everlywell

  • Table 17-63: Everlywell Corporate Summary

Company Overview

Products

COVID-19

Exact Sciences

  • Table 17-64: Exact Sciences Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-65:  Exact Sciences Revenues (2020-2022) ($ millions)

EY Laboratories

  • Table 17-66: EY Laboratories Corporate Summary

Company Overview

Products

First Check Diagnostics LLC

  • Table 17-67:  First Check Diagnostics Corporate Summary

Company Overview

Products

GenBio

  • Table 17-68: GenBio Corporate Summary

Company Overview

Products

Genedrive plc

  • Table 17-69: Genedrive Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-70:  Genedrive Revenues (2020-2022) ($ millions)

GeTein Biotech Inc.

  • Table 17-71: GeTein Corporate Summary

Company Overview

Products

COVID-19

GlysBy diagnostics

  • Table 17-72: GlysBy Corporate Summary

Company Overview

Products

Helena Laboratories

  • Table 17-73: Helena Laboratories Corporate Summary

Company Overview

Products

Hemosure, Inc.

  • Table 17-74: Hemosure Corporate Summary

Company Overview

Products

HORIBA, Ltd.

  • Table 17-75: HORIBA Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-76:  HORIBA Revenues (2020-2022) ($ millions)

Immune IQ

  • Table 17-77: Immune IQ Corporate Summary

Company Overview

Products

Immunosciences Lab, Inc.

  • Table 17-78: Immunosciences Lab Corporate Summary

Company Overview

Products

Immunostics, Inc

  • Table 17-79: Immunostics Corporate Summary

Company Overview

Products

COVID-19

JAL Innovation PTE LTD

  • Table 17-80: JAL Innovation Corporate Summary

Company Overview

Products

Jant Pharmacal Corporation

  • Table 17-81: Jant Pharmacal Corporate Summary

Company Overview

Products

Mitra & Co Pvt. Ltd

  • Table 17-82:  J Mitra Corporate Summary

Company Overview

Products

Covid-19

LamdaGen Corporation

  • Table 17-83: LamdaGen Corporate Summary

Company Overview

Products

COVID-19

LifeScan, Inc

  • Table 17-84: LifeScan Corporate Summary

Company Overview

Products

LifeSign, LLC

  • Table 17-85: LifeSign Corporate Summary

Company Overview

Products

COVID-19

LightDeck Diagnostics

  • Table 17-86: LightDeck  Diagnostics Corporate Summary

Company Overview

Products

COVID-19

LumiraDx UK Limited

  • Table 17-87:  LumiraDx Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-88:  LumiraDx (2020-2022) ($ millions)

Macherey-Nagel GmbH & Co. KG

  • Table 17-89: Macherey-Nagel Corporate Summary

Company Overview

Products

Medix Biochemica

  • Table 17-90: Medix Biochemica Corporate Summary

Company Overview

Products

COVID-19

MedMira, Inc

  • Table 17-91: MedMira Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-92:  MedMira Revenues (2020-2022) ($ thousands)

Medtronic, Inc.

  • Table 17-93: Medtronic Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-94:  Medtronic Revenues (2017-2020) ($ millions)

Menarini Diagnostics srl.

  • Table 17-95: Menarini Diagnostics Corporate Summary

Company Overview

Products

COVID-19

Meridian Bioscience, Inc

  • Table 17-96: Meridian Bioscience Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-97:  Meridian Bioscience (2020-2022) ($ millions)

MiCo BioMed USA

  • Table 17-98: MiCo BioMed Summary

Company Overview

Products

Nano-Ditech Corporation

  • Table 17-99: Nano-Ditech Corporate Summary

Company Overview

Products

COVID-19

NG Biotech

  • Table 17-100: NG Biotech Corporate Summary

Company Overview

Products

COVID-19

Noble Medical, Inc

  • Table 17-101: Noble Medical Corporate Summary

Company Overview

Products

Nova Biomedical Corp.

  • Table 17-102: Nova Biomedical Corporate Summary

Company Overview

Products

Oasis Diagnostics Corporation

  • Table 17-103: Oasis Diagnostics Corporate Summary

Company Overview

Products

Operon S.A.

  • Table 17-104: Operon Corporate Summary

Company Overview

Products

COVID-19

OPKO Health, Inc

  • Table 17-105: OPKO Health Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-106:  OPKO Health Revenues (2020-2022) ($ millions)

OraSure Technologies, Inc.

  • Table 17-107: OraSure Technologies Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-108:  OraSure Revenues (2020-2022) ($ millions)

Polymedco, Inc

  • Table 17-109: Polymedco Corporate Summary

Company Overview

Products

Polymer Technologies, Inc (PTS Diagnostics)

  • Table 17-110: Polymer Technologies Corporate Summary

Company Overview

Products

COVID-19

Preventis GmbH

  • Table 17-111: Preventis Corporate Summary

Company Overview

Products

Princeton Biomeditech Corporation

  • Table 17-112: Princeton Biomeditech Corporate Summary

Company Overview

Products

Covid-19

QuantuMDx Group Limited

  • Table 17-113: QuantuMDx Group Corporate Summary

Company Overview

Products

COVID-19

QuidelOrtho Corporation

  • Table 17-114: Quidel Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-115:  QuidelOrtho Revenues (2020-2022) ($ millions)

Radiometer Medical A/S

  • Table 17-116: Radiometer Medical Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-117:  Radiometer (2020-2022) ($ millions)

Randox Laboratories Limited

  • Table 17-118: Randox Labs Corporate Summary

Company Overview

Products

COVID-19

Response Biomedical Corp

  • Table 17-119: Response Biomedical Corporate Summary

Company Overview

Products

COVID-19

Reszon Diagnostics International Sdn. Bhd.

  • Table 17-120: Reszon Diagnostics Corporate Summary

Company Overview

Products

COVID-19

Rheonix, Inc

  • Table 17-121: Rheonix Corporate Summary

Company Overview

Products

COVID-19

Roche Diagnostic Corporation

  • Table 17-122: Roche Diagnostic Corporate Summary

Company Overview

Products

  • Table 17-123: Roche POC Marketed Products

COVID-19

Performance Review

  • Table 17-124:  Roche Diagnostics (2020-2022) ($ millions)

Savyon Diagnostics

  • Table 17-125: Savyon Diagnostics Corporate Summary

Company Overview

Products

COVID-19

Sekisui Diagnostics LLC

  • Table 17-126: Sekisui Diagnostics Corporate Summary

Company Overview

Products

Siemens Healthineers GmbH

  • Table 17-127: Siemens Healthineers Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-128:  Siemens Healthineers (2020-2022) ($ millions)

Sysmex Corporation

  • Table 17-129: Sysmex Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-130: Sysmex (2020-2022) ($ millions)

TECHLAB, Inc.

  • Table 17-131: TECHLAB Corporate Summary

Company Overview

Products

Trinity Biotech PLC

  • Table 17-132: Trinity Biotech Corporate Summary

Company Overview

Products

COVID-19

Performance Review

  • Table 17-133:  Trinity Biotech Revenue (2020-2022) ($ millions)

Trividia Health

  • Table 17-134: Trividia Health Corporate Summary

Company Overview

Products

Tulip Diagnostics Ltd (Tulip Group)

  • Table 17-135: Tulip Diagnostics Corporate Summary

Company Overview

Product

COVID-19

VedaLab

  • Table 17-136: VedaLab Corporate Summary

Company Overview

Products

COVID-19

Veredus Laboratories PTE Ltd

  • Table 17-137: Veredus Labs Corporate Summary

Company Overview

Products

COVID-19

Werfen

  • Table 17-138:  Werfen Corporate Summary

Company Overview

Products

Performance Review

  • Table 17-139: Werfen (2020-2022) ($ millions)

 

    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
    November 29, 2023
    In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
    November 7, 2023
    30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
    October 27, 2023
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023

Related products

  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Global Medtech Sales Exceed $500 Billion as Chronic Diseases Shape Market’s Future November 14, 2023
  • Healthcare Advances, Investments Support Laboratory Information System (LIS) Growth October 26, 2023
  • Personalized Medicine Key to IVD Procedure Volumes’ 10% Annual Growth October 19, 2023
  • RNA Sequencing: Life Sciences’ Transformative $2.6 Billion Industry October 4, 2023
  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Hematology and Coagulation Markets, 2023 COVID-19 Testing Markets, 2023
Scroll to top